Lymphoma – Ad Ma Place

STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma

Activating mutations in STAT6 are common in Follicular Lymphoma (FL) and transformed FL and various other B cell lymphomas. Here, we report …

AdMaPlace March 11, 2025

0 Comments

The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT

In 2023, 47,731 HCT (20,485 (42.9%) allogeneic and 27,246 (57.1%) autologous) in 43,902 patients were reported by 696 European centers. 6042 patien…

AdMaPlace March 9, 2025

0 Comments

Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

AdMaPlace March 8, 2025

0 Comments

Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection

AdMaPlace March 8, 2025

0 Comments